Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07088822 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers

Study acronym: VEEV
StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 28, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The purpose of the study is to evaluate the safety and immunogenicity of a novel Venezuelan Equine Encephalitis virus (VEEV) vaccine (V4020) for the first time in humans compared to placebo when administered by subcutaneous or intramuscular injection.
Trial Details
NCT Number NCT07088822
Lead Sponsor Medigen, Inc.
Conditions
(from sponsor)		 Venezuelan Equine Encephalitis, Venezuelan Equine Encephalitis Virus Infection
Related terms Encephalomyelitis, Venezuelan Equine
Enrollment 39 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov